Home

Solution

Solution

Streamlining Lynch Syndrome Screening: The Role of Automated MMR IHC Panels in Clinical Routine

Streamlining Lynch Syndrome Screening: The Role of Automated MMR IHC Panels in Clinical Routine

Streamlining Lynch Syndrome Screening: The Role of Automated MMR IHC Panels in Clinical Routine

Optimize Lynch Syndrome screening with Celnovte’s CNT 360. Achieve 98% accuracy and 70% less hands-on time with our automated 4-antibody MMR IHC solutions.

Beyond Tissue: Adapting IHC Techniques for Liquid-Based Cytology (LBC)

Beyond Tissue: Adapting IHC Techniques for Liquid-Based Cytology (LBC)

Beyond Tissue: Adapting IHC Techniques for Liquid-Based Cytology (LBC)

Boost diagnostic accuracy by 20% with Celnovte’s CNT 480 & MicroStacker™. Seamlessly adapt IHC to LBC samples for superior cell adhesion and signal clarity.

Navigating the Gray Area Between HER2 Low and HER2 Negative Status

Distinguishing HER2-Low from HER2-Negative status

Navigating the Gray Area Between HER2 Low and HER2 Negative Status

Navigating the Gray Area Between HER2 Low and HER2 Negative Status

Improve diagnostic accuracy in breast cancer with Celnovte’s HER2 solutions. Our sensitive antibodies and automated stainers clarify the HER2-low gray area.

EBER ISH vs. EBV IHC: Which Method Provides the Most Accurate Gastric Cancer Diagnosis

Comparing EBER ISH and EBV IHC for gastric cancer diagnosis

EBER ISH vs. EBV IHC: Which Method Provides the Most Accurate Gastric Cancer Diagnosis

EBER ISH vs. EBV IHC: Which Method Provides the Most Accurate Gastric Cancer Diagnosis

Discover why EBER ISH outperforms IHC for Gastric Cancer diagnosis. Explore Celnovte’s Super-ISH™ probes and CNT 360 for high-precision EBV detection.